Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

JAZZ holding history

Jazz Pharmaceuticals plc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JAZZ overviewAll 13F holders of JAZZFull Q2 2026 holdings

Shares (Q2 2026)
87,075
Value
$21.0M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of JAZZ by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202687,075$21.0M<0.1%−211,015−70.8%ReducedHolders
Q1 2026298,090$56.4M<0.1%+98,788+49.6%AddedHolders
Q4 2025199,302$33.9M<0.1%+74,936+60.3%AddedHolders
Q3 2025124,366$16.4M<0.1%+120,460+3,084.0%AddedHolders
Q2 20253,906$414.5K<0.1%−62,285−94.1%ReducedHolders
Q1 202566,191$8.22M<0.1%−235,918−78.1%ReducedHolders
Q4 2024302,109$37.2M<0.1%+43,710+16.9%AddedHolders
Q3 2024258,399$28.8M<0.1%+2,528+1.0%AddedHolders
Q2 2024255,871$27.3M<0.1%+48,270+23.3%AddedHolders
Q1 2024207,601$25.0M<0.1%−46,194−18.2%ReducedHolders
Q4 2023253,795$31.2M<0.1%+25,462+11.2%AddedHolders
Q3 2023228,333$29.6M<0.1%−41,387−15.3%ReducedHolders
Q2 2023269,720$33.4M0.1%+132,137+96.0%AddedHolders
Q1 2023137,583$20.1M<0.1%+42,247+44.3%AddedHolders
Q4 202295,336$15.2M<0.1%+95,336NewHolders
Q1 20220$00.0%−6,068−100.0%Sold outHolders
Q4 20216,068$773.0K<0.1%+414+7.3%AddedHolders
Q3 20215,654$736.0K<0.1%−12,374−68.6%ReducedHolders
Q2 202118,028$3.20M<0.1%+1,334+8.0%AddedHolders
Q1 202116,694$2.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.